Back to the main directory
Press Release
- United Fire Group, Inc. Declares a Common Stock Quarterly Cash Dividend of $0.16 per Share by GlobeNewsWire
- Delisting of Securities of Genesis Growth Tech Acquisition Corp.; Financial Strategies Acquisition Corp.; Kiromic BioPharma, Inc.; Infinity Pharmaceuticals, Inc.; Molekule Group, Inc.; EBET, Inc.; Shift Technologies, Inc.; Ontrak, Inc.; RVL Pharmaceutical by GlobeNewsWire
- SiTime Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) by GlobeNewsWire
- Clearmind Medicine Announces Receipt of Nasdaq Delisting Notice and Plan for Immediate Recompliance by GlobeNewsWire
- Secoo Receives Delisting Notice from Nasdaq and Plans to Request Hearing by GlobeNewsWire
- CNH Industrial: Periodic Report on $1 Billion Buyback Program by GlobeNewsWire
- Exela Technologies, Inc. Receives Expected Nasdaq Notice Regarding Late Form 10-Q Filing by GlobeNewsWire
- Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) by GlobeNewsWire
- Mawson Infrastructure Group Inc. Announces Monthly Operational Update for October 2023 by GlobeNewsWire
- Cellectis’ Shareholders Meeting to be Held on December 22, 2023 by GlobeNewsWire
- American Airlines Announces Pricing of Senior Secured Notes by GlobeNewsWire
- Ault Alliance Announces Notice of Noncompliance with NYSE American Listing Standards by BusinessWire
- Granite REIT Declares Distribution for November 2023 by BusinessWire
- National Research Corporation Declares Quarterly Dividend by GlobeNewsWire
- Bombardier Announces Closing of its New Issuance of Senior Notes due 2030 by GlobeNewsWire
- Aurora Spine Grants Stock Options by GlobeNewsWire
- Biophytis announces receipt of Nasdaq Notice by EQS Group AG
- Partners Value Investments L.P. Announces Q3 2023 Interim Results by GlobeNewsWire
- Applied UV Announces Third Quarter 2023 Financial Results, Revenue Increases to $11.4 Million, Adjusted EBITDA (non-GAAP) Improves 30.8% Year Over Year by GlobeNewsWire
- TME PHARMA ANNONCE LA PRESENTATION DE DONNEES ADDITIONELLES SUR LE TRAITEMENT EN COMBINAISON DE NOX-A12 DANS LE CANCER DU CERVEAU A L’OCCASION DE LA REUNION ANNUELLE SNO 2023 by BusinessWire
- Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas by GlobeNewsWire
- MediciNova Announces New Data and Results of a Phase 2 Clinical Trial of MN-166 (ibudilast) in Glioblastoma Presented at the 28th Annual Meeting of the Society for Neuro-Oncology by GlobeNewsWire
- Ensurge Micropower ASA - Grant of Incentive Subscription Rights by GlobeNewsWire
- Oxurion Discloses Topline Data from KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema by GlobeNewsWire
- Standard Lithium Provides Comprehensive Results of Its Fully Optimized and Proven DLE Process by GlobeNewsWire